1. Home
  2. TLYS vs OTLK Comparison

TLYS vs OTLK Comparison

Compare TLYS & OTLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tilly's Inc.

TLYS

Tilly's Inc.

HOLD

Current Price

$5.45

Market Cap

43.3M

ML Signal

HOLD

Logo Outlook Therapeutics Inc.

OTLK

Outlook Therapeutics Inc.

HOLD

Current Price

$1.22

Market Cap

37.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLYS
OTLK
Founded
1982
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.3M
37.5M
IPO Year
2011
2016

Fundamental Metrics

Financial Performance
Metric
TLYS
OTLK
Price
$5.45
$1.22
Analyst Decision
Hold
Buy
Analyst Count
1
4
Target Price
$2.00
$2.50
AVG Volume (30 Days)
381.4K
27.0M
Earning Date
06-03-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
62.34
55.91
EPS
N/A
N/A
Revenue
N/A
$8,146,123.00
Revenue This Year
$4.66
$1,430.98
Revenue Next Year
$1.74
$173.23
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.14
$0.16
52 Week High
$5.90
$3.39

Technical Indicators

Market Signals
Indicator
TLYS
OTLK
Relative Strength Index (RSI) 67.86 82.83
Support Level $3.62 $1.13
Resistance Level $5.72 $1.54
Average True Range (ATR) 0.45 0.15
MACD 0.09 0.04
Stochastic Oscillator 70.83 86.63

Price Performance

Historical Comparison
TLYS
OTLK

About TLYS Tilly's Inc.

Tilly's Inc works as a specialty retailer of casual apparel, footwear, and accessories for young men, young women, boys, and girls. It offers an unparalleled selection of relevant brands, styles, colors, sizes, and price points. It delivers branded fashion, and core styles for tops, outerwear, bottoms, and dresses. It also provides backpacks, hats, sunglasses, headphones, handbags, watches, and jewelry. It markets its products under the brand names of Vans, RVCA, Adidas, Nike SB, and Hurley among others. It operates its stores in malls, lifestyle centers, power centers, community centers, outlet centers, street-front locations, and also through e-commerce.

About OTLK Outlook Therapeutics Inc.

Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA, which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.

Share on Social Networks: